expert roundtables

Improving Long-term Outcomes in Systemic Lupus Erythematosus: Trends and Contributors
Rheumatology

Improving Long-term Outcomes in Systemic Lupus Erythematosus: Trends and Contributors

expert roundtables
By Bevra H. Hahn, MD; George C. Tsokos, MD; Joan T. Merrill, MD
Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma
Oncology

Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD
Newer Options for Durable Disease Control in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Oncology

Newer Options for Durable Disease Control in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD
Biologic Treatment Algorithms for Plaque Psoriasis: Special Populations and Comorbidities in Focus
Dermatology

Biologic Treatment Algorithms for Plaque Psoriasis: Special Populations and Comorbidities in Focus

expert roundtables
By Boni E. Elewski, MD; Bruce E. Strober, MD, PhD, FAAD; Steven R. Feldman, MD, PhD
What Drives the Choice Between Systemic Drugs in the Treatment of Plaque Psoriasis?
Dermatology

What Drives the Choice Between Systemic Drugs in the Treatment of Plaque Psoriasis?

expert roundtables
By Boni E. Elewski, MD; Bruce E. Strober, MD, PhD, FAAD; Steven R. Feldman, MD, PhD
Load More